PP
BIOC

PDS Planning’s Biocept, Inc. BIOC Stock Holding History

PDS Planning’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$2K – 83
2018
Q2 		$2K Hold
1
– – ﹤0.01% 76
2018
Q1 		$3K Hold
1
– – ﹤0.01% 75
2017
Q4 		$7K Buy
+1
New +$7.91K 0.01% 67

Other funds holding BIOC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

PDS Planning's BIOC Position: Q3 2018 in Review

PDS Planning sold out of Biocept, Inc. (BIOC) in Q3 2018, closing a stake of 1 share — an estimated $2K sold.

PDS Planning first reported a position in BIOC in Q4 2017 and held it in 3 quarters. The position peaked at $7K in Q4 2017. 8 funds tracked by Wall St. Rank hold BIOC as of Q3 2018.

  • PDS Planning reported no remaining Biocept, Inc. position as of Q3 2018 after selling out during the quarter.
  • PDS Planning sold 1 Biocept, Inc. share in Q3 2018, an estimated $2K.
  • PDS Planning first reported a position in Biocept, Inc. in Q4 2017 and held it in 3 quarters.
  • PDS Planning's Biocept, Inc. position peaked at $7K in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2018.

Based on PDS Planning's 13F filing for Q3 2018, filed 2 Nov 2018.